Activation for Catalysis of Penicillin-Binding Protein 2a from Methicillin-Resistant Staphylococcus aureus by Bacterial Cell Wall
Authors:
- 1 February 2005
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 127 (7) , 2056-2057
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) has acquired a unique penicillin-binding protein (PBP), PBP 2a, which has rendered the organism resistant to the action of all available β-lactam antibiotics. The X-ray structure of PBP 2a shows the active site in a closed conformation, consistent with resistance to inhibition by β-lactam antibiotics. However, it is known that PBP 2a avidly cross-links the S. aureus cell wall, which is its physiological function. It is shown herein that synthetic fragments of the bacterial cell wall bind in a saturable manner to PBP 2a and cause a conformational change in the protein that makes the active site more accessible to binding to a β-lactam antibiotic. These observations and measurements point to a novel strategy by nature to keep the active site of PBP 2a sheltered from the inhibitory activity of the antibiotics, yet it becomes available to the polymeric cell wall by a requisite conformational change for the critical cell wall cross-linking reaction.Keywords
This publication has 4 references indexed in Scilit:
- The Basis for Resistance to β-Lactam Antibiotics by Penicillin-binding Protein 2a of Methicillin-resistant Staphylococcus aureusJournal of Biological Chemistry, 2004
- The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA)Proceedings of the National Academy of Sciences, 2002
- Evaluation of Current Methods for Detection of Staphylococci with Reduced Susceptibility to GlycopeptidesJournal of Clinical Microbiology, 2001
- Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implicationsClinical Microbiology Reviews, 1997